SMAD7 and neoplasm: miR-181a could act as a tumour suppressor in paediatric ALL by over-expressing its target, small mother against decapentaplegic 7 (Smad7) [38], which regulates TGF-β1 via negative feedback and mediates the interaction between TGF-β1 and other pathways.